Tabrizi, SJ;
Leavitt, B;
Landwehrmeyer, B;
Wild, E;
Salt, C;
Barker, R;
Craufurd, D;
... HTT Rx CS1 study teams, .; + view all
(2018)
Effects of IONIS-HTTRX (RG6042) in Patients With Early Huntington's Disease, Results of the First Htt-lowering Drug Trial.
Presented at: EHDN Plenary Meeting, Vienna, Austria.
Preview |
Text
Tabrizi EHDN 2018 abstract (author affiliations updated).pdf - Accepted Version Download (121kB) | Preview |
| Type: | Conference item (UNSPECIFIED) |
|---|---|
| Title: | Effects of IONIS-HTTRX (RG6042) in Patients With Early Huntington's Disease, Results of the First Htt-lowering Drug Trial |
| Event: | EHDN Plenary Meeting |
| Location: | Vienna, Austria |
| Dates: | 14-16 September 2018 |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1136/jnnp-2018-EHDN.261 |
| Publisher version: | https://jnnp.bmj.com/content/89/Suppl_1/A97.2 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Neurodegenerative Diseases |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10059038 |
Archive Staff Only
 |
View Item |
